Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
29,439 total articles
Braveheart Bio Inc., a San Francisco-based clinical-stage biopharmaceutical company backed by a16z, has filed to raise up to $318.8 million in an initial public offering. The company is offering 18.8 million shares at $15 to $17 apiece, which would value Braveheart at roughly $1.2 billion at the top of the range. Proceeds are tied to advancing BHB-…
AMC Networks stock moved lower in pre-market trading after the company reported a sharply larger-than-expected adjusted loss and weaker-than-anticipated revenue for the quarter ended June 30. The results included an adjusted loss of -$0.28 per share versus analyst expectations of -$0.06 and net revenue of $547.5 million, down 9% year-over-year and …
Futures tied to Canada’s main equity gauge ticked higher Thursday as strong quarterly results from select energy and mining firms coincided with sustained geopolitical pressure in the Middle East. U.S. futures climbed, supported by Microsoft’s results, but gains were limited by regional conflict and Fed commentary that kept rate expectations in flu…
Alnylam Pharmaceuticals plunged in pre-market trading after reporting second-quarter 2026 results that missed revenue expectations and prompted a substantial downward revision to full-year guidance. Management said the outlook change reflects a normalization of second-line patient volumes in the ATTR-CM market following the initial launch surge for…
Sphere Entertainment Co. shares rose in pre-market trading after the company posted second-quarter 2026 results that exceeded Wall Street revenue forecasts. Investors reacted to stronger-than-expected top-line figures, an active content pipeline and ongoing international expansion plans, even as analysts had forecasted a wider loss for the period.
The U.S. National Highway Traffic Safety Administration has granted an exemption allowing Amazon-owned Zoox to commercially deploy steering-wheel-free robotaxis on a limited basis, permitting up to 2,500 vehicles in each of the next two years and subjecting the company to enhanced reporting requirements and potential revocation if safety problems e…
Barclays identified L'Oréal and Unilever as its preferred holdings within European consumer staples, citing sustained demand for premium beauty, accelerating cosmetics consumption globally and the strategic advantage of product innovation combined with focused brand investment. The bank singled out L'Oréal as its clearest preferred name due to robu…
Labcorp raised its 2026 adjusted earnings and revenue guidance after reporting second-quarter results that beat consensus on overall revenue and adjusted EPS. Growth in its drug-development services arm and continued demand for specialty diagnostic testing supported the performance. Shares fell about 6% in premarket trading amid investor attention …
Braveheart Bio filed to go public in the United States seeking a valuation of as much as $1.2 billion. The San Francisco-based clinical-stage company plans to offer 18.8 million shares at $15 to $17 each to raise $318.8 million, with plans to use proceeds to further develop its lead candidate BHB-1893 and support R&D and corporate needs.
BTIG has named Take-Two Interactive a top pick, reiterating an Outperform rating and assigning a $285 price target as the studio prepares to launch Grand Theft Auto VI on November 19. The brokerage is forecasting substantial bookings for fiscal 2027, driven primarily by GTA VI unit sales and premium pricing assumptions, while flagging unanswered qu…
Myers Industries fell in pre-market trade after reporting Q2 2026 results that featured an adjusted EPS of $0.53, beating expectations by $0.21, but revenue of $176.2 million that missed the $208.9 million consensus. The revenue shortfall, rising input cost concerns and a stock that had already rallied sharply contributed to the company-specific we…
HSBC said concerns that hyperscalers may be overspending have become the primary narrative shaping AI-related equity flows. The bank's clustering model, created by analyst Alastair Pinder, partitions the market into five regimes and assigns probabilities to each, indicating potential sector rotations depending on which narrative prevails.
Colliers International shares rose 8.7% in pre-market trading after the company reported second-quarter 2026 results that exceeded analyst expectations for both revenue and earnings. Highlights include double-digit consolidated revenue growth, higher Adjusted EBITDA and EPS above consensus, and management's reaffirmation of mid-teens percentage gro…
Meta Platforms shares tumbled nearly 10% in pre-market trading to $527.24, hovering just above the 52-week low of $520.26, after second-quarter results showed an EPS miss of 13.81% despite revenue edging 1% above estimates. The stock reaction centers on a sharp operating margin contraction of 600 basis points and a lack of guidance on 2027 capital …
Mastercard reported higher second-quarter profit as resilient consumer spending and elevated transaction values helped drive an increase in transaction volumes. Gross dollar volume rose 8% to $2.9 trillion and net revenue increased 14% to $9.3 billion, while net income reached $4.4 billion, or $4.97 per share. Growth in cross-border activity and th…
Two large power companies, Constellation Energy (CEG) and Vistra Energy (VST), have both underperformed year-to-date yet occupy differing positions in the race to supply AI-era data centers. CEG is concentrated on nuclear baseload with long-term offtakes and next-generation nuclear investments, trading at a premium multiple. VST operates a mixed po…
Leonardo DRS rallied after delivering second-quarter results that exceeded analyst expectations, raising full-year guidance and unveiling a $450 million all-cash deal for Raft LLC. The combination of stronger-than-expected earnings, upgraded forecasts and an acquisition aimed at bolstering AI capabilities for national security customers helped push…
Mastercard stock rose sharply in pre-market trading after the company posted stronger-than-expected second-quarter results. Net income climbed to $4.4 billion, or $4.97 per share, driven by solid transaction volumes and cross-border travel payment flows. Analyst upgrades and favorable positioning amplified the market response even as macroeconomic …
Rio Tinto shares rose more than 3% in London after Berenberg and Goldman Sachs upgraded the stock to Buy following the miner's July 29 first-half results. Analysts cited an appealing valuation relative to peers, stronger cash flow and a growing copper franchise as reasons for the move, while pointing to ongoing cost savings and potential proceeds f…
U.S. equity futures advanced on Thursday after Microsoft posted a robust fiscal fourth-quarter beat and signaled its AI investments are translating into demand. Gains were restrained by a hawkish Federal Reserve tone and rising oil prices amid escalating Middle East conflict. Individual corporate results produced volatile premarket moves, with Quan…
Regeneron Pharmaceuticals surged in pre-market trading after reporting second-quarter 2026 results that significantly outpaced analyst forecasts. Adjusted EPS of $14.29 topped consensus by $3.71, and revenue of $4.29 billion beat expectations by a wide margin. Record sales across key franchises and the full repayment of the Sanofi Development Balan…
Regeneron reported second-quarter revenue and profit that exceeded Wall Street expectations, driven by robust global sales of Dupixent and rising uptake of a higher-dose formulation of Eylea in the U.S. The company also completed repayment of an outstanding development balance to Sanofi, a move cited as supportive of margin improvement for the rema…
Avery Dennison Corp. stock climbed sharply in pre-market trading after the company reported second-quarter results that exceeded analyst estimates and provided full-year 2026 EPS guidance that sits at or above consensus. The move came despite a cautious analyst setup heading into the report and was supported by a positive broader market backdrop.
UBS has revised up its 2026 forecasts for China’s trade, pointing to AI-related commerce as a dominant factor in stronger-than-expected performance in the first half of 2026. Exports rose 18% year-over-year and imports 26% in H1, with AI-linked trade accounting for nearly half of growth. UBS now expects 2026 nominal export growth of about 18% and i…
Baxter International rallied sharply in pre-market trading after delivering second-quarter 2026 results that outpaced analyst forecasts on both earnings and revenue, and after lifting its full-year adjusted EPS guidance. The company also shifted to a two-segment reporting model aimed at clearer visibility into core operations. The combination of th…
